PathoVax's Incubator/Accelerator - III Round

PathoVax raised a round of funding on December 21, 2016. Investors include Harvard Life Lab.

PathoVax is a biotech company developing a cost-effective human papillomavirus (HPV) vaccine machine with universal protection. PathoVax's pilot vaccine RGVax promises to provide protection against al…

Articles about PathoVax's Incubator/Accelerator - III Round: